$22.65
0.04%
NYSE, Oct 31, 09:00 pm CET
ISIN
US71944F1066
Symbol
PHR

Phreesia Inc Stock price

$22.64
-0.88 3.74% 1M
-2.32 9.29% 6M
-2.52 10.02% YTD
+4.35 23.78% 1Y
-4.68 17.13% 3Y
-13.81 37.89% 5Y
-2.44 9.73% 10Y
-2.44 9.73% 20Y
NYSE, Closing price Fri, Oct 31 2025
-0.02 0.09%
ISIN
US71944F1066
Symbol
PHR

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.3b
Net debt
positive
Cash
$98.3m
Shares outstanding
59.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.0 | 2.8
EV/Sales
2.8 | 2.6
EV/FCF
45.5
P/B
4.6
Financial Health
Equity Ratio
68.2%
Return on Equity
-22.1%
ROCE
-8.7%
ROIC
-11.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$449.7m | $482.7m
EBITDA
$2.0m | $90.8m
EBIT
$-26.2m | $-5.5m
Net Income
$-24.1m | $-3.0m
Free Cash Flow
$27.9m
Growth (TTM | estimate)
Revenue
15.3% | 15.0%
EBITDA
102.8% | 400.6%
EBIT
73.6% | 90.5%
Net Income
76.0% | 94.8%
Free Cash Flow
211.3%
Margin (TTM | estimate)
Gross
68.0%
EBITDA
0.4% | 18.8%
EBIT
-5.8%
Net
-5.4% | -0.6%
Free Cash Flow
6.2%
More
EPS
$-0.4
FCF per Share
$0.5
Short interest
6.5%
Employees
2k
Rev per Employee
$200.0k
Show more

Is Phreesia Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Phreesia Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Phreesia Inc forecast:

19x Buy
95%
1x Hold
5%

Analyst Opinions

20 Analysts have issued a Phreesia Inc forecast:

Buy
95%
Hold
5%

Financial data from Phreesia Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '25
+/-
%
450 450
15% 15%
100%
- Direct Costs 144 144
11% 11%
32%
306 306
17% 17%
68%
- Selling and Administrative Expenses 182 182
14% 14%
40%
- Research and Development Expense 120 120
3% 3%
27%
1.95 1.95
103% 103%
0%
- Depreciation and Amortization 28 28
5% 5%
6%
EBIT (Operating Income) EBIT -26 -26
74% 74%
-6%
Net Profit -24 -24
76% 76%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about Phreesia Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Phreesia Inc Stock News

Positive
The Motley Fool
6 days ago
The Capricorn Fund acquired 484,500 shares in Phreesia; estimated trade value of $11.40 million based on the average price during the quartea The trade represents 3.8% of 13F reportable AUM Post-trade stake totals 484,500 shares, valued at $11.40 million as of September 30, 2025 New position places Phreesia outside the fund's top five holdings
Neutral
Business Wire
25 days ago
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories.
Neutral
Business Wire
about one month ago
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to TIME's list of the World's Top HealthTech Companies of 2025.
More Phreesia Inc News

Company Profile

Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.

Head office United States
CEO Chaim Indig
Employees 2,082
Founded 2005
Website www.phreesia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today